Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Giuseppina Greco"'
Autor:
Nicola Di Renzo, Lorella Melillo, Fernando Porretto, Michela Dargenio, Vincenzo Pavone, Domenico Pastore, Patrizio Mazza, Donato Mannina, Anxur Merenda, Nicola Cascavilla, Giuseppina Greco, Rosella Matera, Erminio Bonizzoni, Luigi Celio, Maurizio Musso
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 170-178 (2020)
Abstract Background Compared with older 5‐HT3 receptor antagonists, palonosetron requires fewer drug administrations to prevent chemotherapy‐induced nausea and vomiting (CINV) following multiple‐day chemotherapy. We conducted a phase II multice
Externí odkaz:
https://doaj.org/article/5b06c7a30b884f91adc80f51334f5b79
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 27(1)
Autor:
Eros Di Bona, Margherita Sciumé, Monica Bocchia, Gianpaolo Nadali, Monica Fumagalli, Monica Crugnola, Carlotta Galeone, Marzia Defina, Alfredo Molteni, Daniela Lambertenghi Deliliers, Silvia Imbergamo, Emanuela Caizzi, Giuseppina Greco, Nicola Stefano Fracchiolla, Roberto Latagliata, Anna Sicuranza, Claudia Basilico, Carla Filì, Vincenzo Sammartano, Giuseppe Rossi, Francesco Rotondo, Mariagrazia Michieli, Enrico Capochiani, Claudio Pelucchi, Giulia Alunni, Barbara Scappini, Massimo Bernardi, Marta Riva, Francesco Mazziotta, Chiara Cattaneo, Marianna Rossi, Giulia Fontanelli, Erika Borlenghi, Anna Candoni, Michele Gottardi, Catia Bigazzi, Ugo Consoli, Renato Fanin, Federico Simonetti, Elisabetta Todisco, Michela Rondoni, Anna Ermacora
Publikováno v:
Hematological Oncology. 37:447-455
Despite widespread use of decitabine to treat acute myeloid leukaemia (AML), data on its effectiveness and safety in the real-world setting are scanty. Thus, to analyze the performance of decitabine in clinical practice, we pooled together patient-le
Autor:
Anna Mele, Attilio Guarini, Nicola Cascavilla, Rita Rizzi, Sabrina Sabatelli, E. Prete, Maria Rosaria Morciano, Patrizio Mazza, Antonietta Falcone, Lorenzo Tonialini, Domenico Pastore, Carolina Vergine, Massimo Offidani, Silvia Sibilla, Rosa De Francesco, Giuseppe Tarantini, Vincenzo Pavone, Giuseppe Mele, Giuseppina Greco, Angela Giannotta, Giorgina Specchia, Gaetano Palumbo, Silvana Capalbo, Stefania Citiso, Clara De Risi, Nicola Di Renzo, Giulia Palazzo, Giovanni Reddiconto, Paola Curci, Grazia Sanpaolo, Antonino Greco, Candida Germano, R. Miccolis
Publikováno v:
Annals of hematology. 100(2)
Carfilzomib, lenalidomide, and dexamethasone (KRd) have been approved for the treatment of relapsed and refractory multiple myeloma (RRMM) based on ASPIRE clinical trial. However, its effectiveness and safety profile in real clinical practice should
Autor:
Michelina Dargenio, Giuseppe Tarantini, Nicola Cascavilla, Enzo Pavone, Pellegrino Musto, Patrizio Mazza, Lorella Melillo, Domenico Pastore, Attilio Guarini, Caterina Buquicchio, Maria Paola Fina, Vincenzo Federico, Teresa Maria Santeramo, Marina Aurora Urbano, Mariangela Leo, Vera Carluccio, Paola Carluccio, Mario Delia, Daniela Carlino, Carolina Vergine, Vito Pier Gagliardi, Giuseppina Greco, Silvia Sibilla, Mariachiara Abbenante, Giovanni Rossi, Giuseppina Spinosa, Annamaria Mazzone, Lara Aprile, Vincenza de Fazio, Crescenza Pasciolla, Giorgina Specchia, Nicola Di Renzo
Publikováno v:
Cancers, Vol 14, Iss 826, p 826 (2022)
Cancers; Volume 14; Issue 3; Pages: 826
Cancers; Volume 14; Issue 3; Pages: 826
Decitabine, a DNA hypomethylating agent, was approved for use in adults with acute myeloid leukemia (AML) not eligible for standard chemotherapy and is now widely accepted as standard treatment. Although a number of clinical trials demonstrated its b
Autor:
Michela Rondoni, Elisabetta Todisco, Daniela Lambertenghi Deliliers, Catia Bigazzi, Barbara Scappini, Michele Gottardi, Massimo Bernardi, Francesco Mazziotta, Maria Grazia Michieli, Giuseppe Rossi, Marianna Rossi, Marta Riva, Gianpaolo Nadali, Eros Di Bona, Anna Candoni, Emanuela Caizzi, Renato Fanin, Monica Fumagalli, Margherita Sciumé, Alfredo Molteni, Claudia Basilico, Monica Bocchia, Carla Filì, Giulia Fontanelli, Nicola Stefano Fracchiolla, Ugo Consoli, Vincenzo Sammartano, Erika Borlenghi, Francesco Rotondo, Roberto Latagliata, Giulia Alunni, Carlotta Galeone, Silvia Imbergamo, Chiara Cattaneo, Claudio Pelucchi, Enrico Capochiani, Anna Ermacora, Marzia Defina, Giuseppina Greco, Federico Simonetti, Monica Crugnola, Anna Sicuranza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83498a98f0725c866016b0430e96e892
https://doi.org/10.1002/hon.2663/v2/response1
https://doi.org/10.1002/hon.2663/v2/response1
Autor:
Michela Dargenio, Giuseppina Greco, Patrizio Mazza, Luigi Celio, Vincenzo Pavone, Nicola Di Renzo, Erminio Bonizzoni, Anxur Merenda, Rosella Matera, Lorella Melillo, Donato Mannina, Nicola Cascavilla, Maurizio Musso, Domenico Pastore, Fernando Porretto
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 1, Pp 170-178 (2020)
Cancer Medicine, Vol 9, Iss 1, Pp 170-178 (2020)
Background Compared with older 5‐HT3 receptor antagonists, palonosetron requires fewer drug administrations to prevent chemotherapy‐induced nausea and vomiting (CINV) following multiple‐day chemotherapy. We conducted a phase II multicenter stud
Autor:
R. De Francesco, A. Falcone, S. Citiso, E. Prete, Attilio Guarini, N. Di Renzo, Carolina Vergine, M.R. Morciano, Anna Mele, Rita Rizzi, Giuseppe Tarantini, S. Sabatelli, Angela Giannotta, Giulia Palazzo, Candida Germano, Silvana Capalbo, Vincenzo Pavone, Domenico Pastore, Paola Curci, Antonino Greco, Silvia Sibilla, Nicola Cascavilla, C. De Risi, Giovanni Reddiconto, Giuseppina Mele, Giorgina Specchia, Giuseppina Greco, Patrizio Mazza, Grazia Sanpaolo, R. Miccolis
Publikováno v:
HemaSphere. 3:275-276
Autor:
E. La Rosa, R. De Blasi, M. Tridici, Vincenzo Pavone, L. Tonialini, C. De Risi, Antonino Greco, Silvia Sibilla, Giuseppina Greco, E. Prete, S. Citiso, M.R. Morciano, Anna Mele, A. Notaristefano, R. De Francesco
Publikováno v:
Hematological Oncology. 37:548-548
Autor:
Angela Melpignano, Giuseppina Greco, Vincenzo Pavone, Giorgina Specchia, Mario Delia, Nicola Cascavilla, Patrizio Mazza, Silvana Capalbo, Caterina Buquicchio, Nicola Di Renzo, Attilio Guarini, Carolina Vergine, Lorella Melillo, Giuseppe Tarantini, Barbara Amurri, Paola Carluccio
Publikováno v:
Leukemia research.
The optimal treatment of older patients (>65 years) with acute myeloid leukemia (AML) remains challenging in daily clinical practice; a choice has to be made between intensive chemotherapy and best supportive care. To guide physicians, several progno